Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation

  • Nat Commun. 2013;4:1338. doi: 10.1038/ncomms2334.
Isabel Romero-Camarero  1 ,  Xiaoyu Jiang ,  Yasodha Natkunam ,  Xiaoqing Lu ,  Carolina Vicente-Dueñas ,  Ines Gonzalez-Herrero ,  Teresa Flores ,  Juan Luis Garcia ,  George McNamara ,  Christian Kunder ,  Shuchun Zhao ,  Victor Segura ,  Lorena Fontan ,  Jose A Martínez-Climent ,  Francisco Javier García-Criado ,  Jason D Theis ,  Ahmet Dogan ,  Elena Campos-Sánchez ,  Michael R Green ,  Ash A Alizadeh ,  Cesar Cobaleda ,  Isidro Sánchez-García ,  Izidore S Lossos
Affiliations
  • 1. Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, 37007 Salamanca, Spain.
Abstract

The human germinal centre-associated lymphoma gene is specifically expressed in germinal centre B-lymphocytes and germinal centre-derived B-cell lymphomas, but its function is largely unknown. Here we demonstrate that human germinal centre-associated lymphoma directly binds to Syk in B cells, increases its kinase activity on B-cell receptor stimulation and leads to enhanced activation of Syk downstream effectors. To further investigate these findings in vivo, human germinal centre-associated lymphoma transgenic mice were generated. Starting from 12 months of age these mice developed polyclonal B-cell lymphoid hyperplasia, hypergammaglobulinemia and systemic reactive amyloid A (AA) amyloidosis, leading to shortened survival. The lymphoid hyperplasia in the human germinal centre-associated lymphoma transgenic mice are likely attributable to enhanced B-cell receptor signalling as shown by increased Syk phosphorylation, ex vivo B-cell proliferation and increased RhoA activation. Overall, our study shows for the first time that the germinal centre protein human germinal centre-associated lymphoma regulates B-cell receptor signalling in B-lymphocytes which, without appropriate control, may lead to B-cell lymphoproliferation.